Predictive, personalized, preventive, participatory (P4) cancer medicine

@article{Hood2011PredictivePP,
  title={Predictive, personalized, preventive, participatory (P4) cancer medicine},
  author={Leroy E. Hood and Stephen H. Friend},
  journal={Nature Reviews Clinical Oncology},
  year={2011},
  volume={8},
  pages={184-187}
}
  • L. Hood, S. Friend
  • Published 1 March 2011
  • Medicine
  • Nature Reviews Clinical Oncology
Medicine will move from a reactive to a proactive discipline over the next decade—a discipline that is predictive, personalized, preventive and participatory (P4). P4 medicine will be fueled by systems approaches to disease, emerging technologies and analytical tools. There will be two major challenges to achieving P4 medicine—technical and societal barriers—and the societal barriers will prove the most challenging. How do we bring patients, physicians and members of the health-care community… 
Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis
TLDR
Beyond the integration of genomic medicine and predictive biomarkers into practice, patient empowerment and participatory medicine are gaining increasing attention, and are especially crucial in paving the way towards optimized healthcare in complex and chronic neurological diseases, such as multiple sclerosis.
A population approach to precision medicine.
Participatory medicine: a driving force for revolutionizing healthcare
TLDR
It is predicted that in 5 to 10 years each patient will be surrounded by a virtual cloud of billions of data points - molecular, clinical chemistries, cellular, organ, phenotypic, imaging, social networks, and so on, and this big data cloud will be reduced to simple models that will guide improvements in health and minimize disease.
The future of Connected Health in preventive medicine.
TLDR
The goal of a CH program that uses genetic data would be to monitor individuals' risk factors and predict the onset of CD, coupled with coaching to delay or prevent the onsetof disease.
Title Problems , challenges and promises : perspectives on precisionmedicine
TLDR
Key concepts and challenges of precision medicine are introduced and some of the approaches currently being implemented to overcome these challenges are introduced.
The P4 Health Spectrum – A Predictive, Preventive, Personalized and Participatory Continuum for Promoting Healthspan
TLDR
A ‘P4 Health Continuum’ model is proposed as a framework to promote and facilitate multi-stakeholder collaboration with an orchestrated common language and an integrated care model to increase the healthspan.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Essentials Of Genomic And Personalized Medicine
TLDR
From principles, methodology and translational approaches to genome discoveries and clinical applications, "Essentials of Genomic and Personalized Medicine" will be a valuable resource for various professionals and students across medical disciplines, including human genetics and genomics, oncology, neuroscience, gene therapy, molecular medicine, pharmacology, and biomedical sciences.
Predictive, preventive, personalized and participatory medicine: back to the future
TLDR
To effectively develop systems medicine, the lessons of the HLA saga should be taken advantage, emphasizing the importance of exploring a fascinating but mysterious biology, now using systems principles, pioneering new technology developments and creating shared biological and information resources.
Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.
TLDR
In this review, systems biology is defined, the current capabilities of proteomics are discussed and some of the necessary milestones for moving systems biology and proteomics into mainstream health care are highlighted.
Cancer Biomarkers—An Invitation to the Table
TLDR
The ongoing efforts to identify and to validate cancer biomarkers are described, the technological hurdles that lie ahead are discussed, and the more pressing political and cultural issues that, if left unheeded, could derail many of the anticipated benefits of biomarker research.
WIN Consortium—challenges and advances
TLDR
The WIN Consortium promotes collaboration between critical stakeholders and offers diverse populations of cancer patients the opportunity to participate in clinical trials with new drugs and biologics that target their tumor.
Through a glass darkly: advances in understanding breast cancer biology, 2000-2010.
  • L. Carey
  • Biology
    Clinical breast cancer
  • 2010
TLDR
Despite therapeutic advances and the development of a number of targeted agents against hormone receptor signaling, HER2, and angiogenesis, the need for more tissue-based studies to allow us to understand the mechanisms of sensitivity and resistance within and across subtypes, and the need to revisit risk and prevention by subtype.
Molecular profiling of breast cancer: clinical implications
TLDR
The recent development of gene expression microarray and related technologies provides an opportunity to perform more detailed profiling of the disease and it is anticipated that the molecular classification arising from such studies will be more powerful than its pathological predecessor at confining treatment to those patients who are most likely to benefit.
International network of cancer genome projects
TLDR
Systematic studies of more than 25,000 cancer genomes will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
The Love/Avon Army of Women: A "just in time" resource to encourage research in women.
TLDR
The Love/Avon Army of Women is a just in time resource for breast cancer scientists to obtain exactly the specimens: breast or adipose tissue, ductal fluid, urine, saliva, blood, or information processed exactly as needed.
An integrative genomics approach to infer causal associations between gene expression and disease
TLDR
It is shown that this approach can predict transcriptional responses to single gene–perturbation experiments using gene-expression data in the context of a segregating mouse population and the utility of this approach is demonstrated by identifying and experimentally validating the involvement of three new genes in susceptibility to obesity.
...
1
2
3
...